FOLFIRI as second-line treatment of metastatic biliary tract cancer patients

The combination of cisplatin and gemcitabine is the standard first-line treatment of metastatic biliary tract cancer (BTC) patients. The benefit of second-line chemotherapy in these patients is controversial. This study aims to evaluate the activity of FOLFIRI (fluorouracil and irinotecan) after fai...

Descripción completa

Detalles Bibliográficos
Autores principales: Caparica, Rafael, Lengelé, Adrien, Bekolo, Winnie, Hendlisz, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: São Paulo, SP: Universidade de São Paulo, Hospital Universitário 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738847/
https://www.ncbi.nlm.nih.gov/pubmed/31528622
http://dx.doi.org/10.4322/acr.2019.087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738847/
https://www.ncbi.nlm.nih.gov/pubmed/31528622
http://dx.doi.org/10.4322/acr.2019.087

Ejemplares similares